Microtubule destabilising agents: far more than just antimitotic anticancer drugs

D Bates, A Eastman - British journal of clinical pharmacology, 2017 - Wiley Online Library
Vinca alkaloids have been approved as anticancer drugs for more than 50 years. They have
been classified as cytotoxic chemotherapy drugs that act during cellular mitosis, enabling …

Targeting the mitotic catastrophe signaling pathway in cancer

MM Mc Gee - Mediators of inflammation, 2015 - Wiley Online Library
Mitotic catastrophe, as defined in 2012 by the International Nomenclature Committee on Cell
Death, is a bona fide intrinsic oncosuppressive mechanism that senses mitotic failure and …

Developmental mRNA m5C landscape and regulatory innovations of massive m5C modification of maternal mRNAs in animals

J Liu, T Huang, W Chen, C Ding, T Zhao, X Zhao… - Nature …, 2022 - nature.com
Abstract m5C is one of the longest-known RNA modifications, however, its developmental
dynamics, functions, and evolution in mRNAs remain largely unknown. Here, we generate …

[HTML][HTML] Future prospects for mitosis-targeted antitumor therapies

A Serrano-del Valle, C Reina-Ortiz, A Benedi… - Biochemical …, 2021 - Elsevier
Dysregulation of cell cycle progression is a hallmark of cancer cells. In recent years, efforts
have been devoted to the development of new therapies that target proteins involved in cell …

PM2. 5 deregulated microRNA and inflammatory microenvironment in lung injury

G Liu, Y Li, J Zhou, J Xu, B Yang - Environmental Toxicology and …, 2022 - Elsevier
PM2. 5 negatively affects human health, particularly lung injury. However, the role of PM2. 5-
regulated miRNAs in lung injury remains unknown. MiRNA array results showed mmu-miR …

An overview on anti-tubulin agents for the treatment of lymphoma patients

M Barreca, A Stathis, P Barraja, F Bertoni - Pharmacology & therapeutics, 2020 - Elsevier
Anti-tubulin agents constitute a large class of compounds with broad activity both in solid
tumors and hematologic malignancies, due to the interference with microtubule dynamics …

Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer …

J Leng, Y Zhao, P Sheng, Y **a, T Chen… - Journal of medicinal …, 2022 - ACS Publications
Natural products are a major source of anticancer agents and play critical roles in anticancer
drug development. Inspired by the complexity-to-diversity strategy, novel …

Perturbing mitosis for anti‐cancer therapy: is cell death the only answer?

M Haschka, G Karbon, LL Fava, A Villunger - EMBO reports, 2018 - embopress.org
Interfering with mitosis for cancer treatment is an old concept that has proven highly
successful in the clinics. Microtubule poisons are used to treat patients with different types of …

MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment

MD Haschka, G Karbon, C Soratroi, KL O'Neill… - Cell Death & …, 2020 - nature.com
Cells experiencing delays in mitotic progression are prone to undergo apoptosis unless they
can exit mitosis before proapoptotic factors reach a critical threshold. Microtubule targeting …

[HTML][HTML] Nocodazole induced suicidal death of human erythrocytes

E Signoretto, S Honisch, M Briglia, C Faggio… - Cellular Physiology and …, 2016 - karger.com
Background: The microtubule assembly inhibitor nocodazole has been shown to trigger
caspase-independent mitotic death and caspase dependent apoptosis. Similar to apoptosis …